Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application
- 1 March 1983
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 33 (3) , 343-350
- https://doi.org/10.1038/clpt.1983.43
Abstract
Tixocortol pivalate is a corticosteroid with topical antiinflammatory activity equal to that of hydrocortisone. It was evaluated in a group of 18 normal subjects to determine whether it exerted any systemic glucocorticoid activity after single oral or intrarectal doses and after short-term dosing by the intranasal route. Effects of tixocortol pivalate were compared to those of oral dexamethasone and intrarectal betamethasone 21-phosphate. By the 3 routes, tixocortol pivalate does not induce any changes in plasma cortisol, leukocyte counts (neutrophils, lymphocytes, monocytes, eosinophils), blood glucose or 24-h urinary excretion of Na+ and K+, whereas there were changes after dexamethasone and betamethasone. Tixocortol pivalate increased urinary free cortisol-like substances. Apparently tixocortol pivalate given for short periods by nonparenteral routes does not induce a measurable systemic glucocorticoid effect.This publication has 2 references indexed in Scilit:
- Rate of Adrenal Cortisol Production in Response to Maximal Stimulation with ACTHJournal of Clinical Endocrinology & Metabolism, 1963
- TESTS OF PITUITARY-ADRENAL SUPPRESSIBILITY IN THE DIAGNOSIS OF CUSHING'S SYNDROME*Journal of Clinical Endocrinology & Metabolism, 1960